Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins

REFERENCES

• Pepose JS, Wilhelmus KR. Divergent approaches to the management of corneal ulcers. Am J Ophthalmol 1992; 114: 630–632.
   PubMed Web of Science ®Google Scholar
• Keay L, Edwards K, Stapleton F. Referral pathways and management of contact lens‐related microbial keratitis in Australia and New Zealand. Clin Experiment Ophthalmol 2008; 36: 209–216.
   Web of Science ®Google Scholar
• Jones DB. Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears. Surv Ophthalmol 1979; 24: 97, 105–116.
   Google Scholar
• O'brien TP. Management of bacterial keratitis: beyond exorcism towards consideration of organism and host factors. Eye 2003; 17: 957–974.
   PubMed Web of Science ®Google Scholar
• Mcallum PJ, Mcghee CN. Prescribing trends in infectious keratitis: a survey of New Zealand ophthalmologists. Clin Experiment Ophthalmol 2003; 31: 496–504.
   Web of Science ®Google Scholar
• Leibowitz HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991; 112: 34S–47S.
   PubMed Web of Science ®Google Scholar
• Honig MA, Cohen EJ, Rapuano CJ, Laibson PR. Corneal ulcers and the use of topical fluoroquinolones. CLAO J 1999; 25: 200–203.
   Google Scholar
• O'brien TP, Maguire MG, Fink NE, Alfonso E, Mcdonnell P. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol 1995; 113: 1257–1265.
   PubMedGoogle Scholar
• Hyndiuk RA, Eiferman RA, Caldwell DR, Rosenwasser GO, Santos CI, Katz HR, Badrinath SS et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin‐cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology 1996; 103: 1854–1862.
   PubMed Web of Science ®Google Scholar
• Parks DJ, Abrams DA, Sarfarazi FA, Katz HR. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol 1993; 115: 471–477.
   PubMed Web of Science ®Google Scholar
• The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double‐masked, randomized, controlled trial with conventional dual therapy. Ophthalmology 1997; 104: 1902–1909.
   Web of Science ®Google Scholar
• Ly CN, Pham JN, Badenoch PR, Bell SM, Hawkins G, Rafferty DL, Mcclellan KA. Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin. Clin Experiment Ophthalmol 2006; 34: 44–50.
   PubMed Web of Science ®Google Scholar
• Schein OD, Glynn RJ, Poggio EC, Seddon JM, Kenyon KR, the Microbial Keratitis Study Group. The relative risk of ulcerative keratitis among users of daily‐wear and extended‐wear soft contact lenses. A case‐control study. N Engl J Med 1989; 321: 773–8.
   PubMed Web of Science ®Google Scholar
• Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea 2008; 27: 22–27.
   PubMed Web of Science ®Google Scholar
• Mcdonnell PJ, Nobe J, Gauderman WJ, Lee P, Aiello A, Trousdale M. Community care of corneal ulcers. Am J Ophthalmol 1992; 114: 531–538.
   Web of Science ®Google Scholar
• Keay L, Edwards K, Dart J, Stapleton F. Grading contact lens‐related microbial keratitis: relevance to disease burden. Optom Vis Sci 2008; 85: 531–537.
   PubMed Web of Science ®Google Scholar
• Keay L, Edwards K, Naduvilath T, Taylor HR, Snibson GR, Forde K, Stapleton F. Microbial keratitis predisposing factors and morbidity. Ophthalmology 2006; 113: 109–116.
   PubMed Web of Science ®Google Scholar
• Wilhelmus KR, Abshire RL, Schlech BA. Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone‐treated bacterial keratitis. Arch Ophthalmol 2003; 121: 1229–1233.
   PubMed Web of Science ®Google Scholar
• Rodman RC, Spisak S, Sugar A, Meyer RF, Soong HK, Musch DC. The utility of culturing corneal ulcers in a tertiary referral center versus a general ophthalmology clinic. Ophthalmology 1997; 104: 1897–1901.
   PubMed Web of Science ®Google Scholar
• Hall RC, Mckellar MJ. Bacterial keratitis in Christchurch, New Zealand, 1997–2001. Clin Experiment Ophthalmol 2004; 32: 478–481.
   Web of Science ®Google Scholar
• Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000; 107: 1497–1502.
   PubMed Web of Science ®Google Scholar
• Yeh DL, Stinnett SS, Afshari NA. Analysis of bacterial cultures in infectious keratitis, 1997 to 2004. Am J Ophthalmol 2006; 142: 1066–1068.
   PubMed Web of Science ®Google Scholar
• Morrissey I, Burnett R, Viljoen L, Robbins M. Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002. J Infect 2004; 49: 109–114.
   PubMed Web of Science ®Google Scholar
• Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5‐year review. Ophthalmology 1999; 106: 1313–1318.
   PubMed Web of Science ®Google Scholar
• Marangon FB, Miller D, Muallem MS, Romano AC, Alfonso EC. Ciprofloxacin and levofloxacin resistance among methicillin‐sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol 2004; 137: 453–458.
   PubMed Web of Science ®Google Scholar
• Freidlin J, Acharya N, Lietman TM, Cevallos V, Whitcher JP, Margolis TP. Spectrum of eye disease caused by methicillin‐resistant Staphylococcus aureus. Am J Ophthalmol 2007; 144: 313–315.
   PubMed Web of Science ®Google Scholar
• Afshari NA, Ma JJK, Duncan SM, Pineda R, Starr CE, Decroos FC, Johnson CS et al. Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis. J Ocular Pharmacol Ther 2008; 24: 217–223.
   Web of Science ®Google Scholar
• Knauf HP, Silvany R, Southern RM, Risser RC, Wilson SE. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea 1996; 15: 66–71.
   Web of Science ®Google Scholar
• Chaudhry NA, Flynn HW Jr, Murray TG, Tabandeh H, Mello MO Jr, Miller D. Emerging ciprofloxacin‐resistant Pseudomonas aeruginosa. Am J Ophthalmol 1999; 128: 509–510.
   PubMed Web of Science ®Google Scholar
• Schaefer F, Bruttin O, Zografos L, Guex‐crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 2001; 85: 842–847.
   PubMed Web of Science ®Google Scholar
• Kunimoto DY, Sharma S, Garg P, Rao GN. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. Ophthalmology 1999; 106: 80–85.
   PubMed Web of Science ®Google Scholar
• Jayahar MB, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. In vitro efficacy of antibacterials against bacterial isolates from corneal ulcers. Indian J Ophthalmol 2002; 50: 109–114.
   Google Scholar
• Sharma V, Sharma S, Garg P, Rao GN. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy. Indian J Ophthalmol. 2004; 52: 287–292.
   PubMedGoogle Scholar
• Garg P, Sharma S, Rao GN. Ciprofloxacin‐resistant Pseudomonas keratitis. Ophthalmology 1999; 106: 1319–1323.
   PubMed Web of Science ®Google Scholar
• Smitha S, Lalitha P, Prajna VN, Srinivasan M. Susceptibility trends of Pseudomonas species from corneal ulcers. Indian J Med Microbiol 2004; 23: 168–171.
   Google Scholar
• Sharma S, Kunimoto DY, Garg P, Rao GN. Trends in antibiotic resistance of corneal pathogens: Part I. An analysis of commonly used ocular antibiotics. Indian J Ophthalmol 1999; 47: 95–100.
   Google Scholar
• Chalita MR, Höfling‐lima AL, Paranhos A, Schor P, Belfort R. Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15-years. Am J Ophthalmol 2004; 137: 43–51.
   PubMed Web of Science ®Google Scholar
• Oliveira ADD, D'azevedo PA, Francisco W, Höfling‐lima AL. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil. Cornea 2007; 26: 194–198.
   PubMed Web of Science ®Google Scholar
• Moriyama AS, Hofling‐lima Al. Contact lens‐associated microbial keratitis. Arq Bras Oftalmol 2008; 71: s32‐s36.
   PubMed Web of Science ®Google Scholar
• Höfling‐lima AL, Belfort R Jr, Moeller CTA, Branco BC, De sousa LB, De freitas D. In vitro antibiotic susceptibilities of ocular bacteria isolates from the cornea and conjunctiva to moxifloxacin, gatifloxacin and other fluoroquinolones. Arq Bras Oftalmol 2004; 67: 883–886.
   Google Scholar
• Fong C‐F, Hu F‐R, Tseng C‐H, Jong wang I, Chen W‐L, Hou Y‐C. Antibiotic susceptibility of bacterial isolates from bacterial keratitis cases in a university hospital in Taiwan. Am J Ophthalmol 2007; 144: 682–689.
   PubMed Web of Science ®Google Scholar
• Tuft SJ, Matheson M. In vitro antibiotic resistance in bacterial keratitis in London. Br J Ophthalmol 2000; 84: 687–691.
   Web of Science ®Google Scholar
• Leibovitch I, Lai TF, Senarath L, Hsuan J, Selva D. Infectious keratitis in South Australia: emerging resistance to cephazolin. Eur J Ophthalmol 2005; 15: 23–26.
   Web of Science ®Google Scholar
• Barton MD, Pratt R, Hart WS. Antibiotic resistance in animals. Commun Dis Intell 2007; 27: S121‐S126.
   Google Scholar
• Livesey JE, Chiew YF. Antimicrobial drug utilisation in Dunedin Hospital, New Zealand, and its association with antimicrobial resistance. Pathology 2006; 38: 245–248.
   PubMed Web of Science ®Google Scholar
• Unal S, Garcia‐rodriguez JA. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002–2004. Diagn Microbiol Infect Dis 2005; 53: 265–271.
   PubMed Web of Science ®Google Scholar
• Nimmo GR, Bell JM, Mitchell D, Gosbell IB, Pearman JW, Turnidge JD. AGAR. Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989–1999. Microbial Drug Resist 2003; 9: 155–160.
   PubMed Web of Science ®Google Scholar
• Kumhar GD, Ramachandran VG, Gupta P. Bacteriological analysis of blood culture isolates from neonates in a tertiary care hospital in India. J Health Pop Nutr 2002; 20: 343–347.
   PubMed Web of Science ®Google Scholar
• Loureiro MM, De moraes BA, Mendonca VL, Quadra MR, Pinheiro GS, Asensi MD. Pseudomonas aeruginosa: study of antibiotic resistance and molecular typing in hospital infection cases in a neonatal intensive care unit from Rio de Janeiro City, Brazil. Mem Inst Oswaldo Cruz 2002; 97: 387–394.
   PubMed Web of Science ®Google Scholar
• Willcox M, Sankaridurg PR, Zhu H, Hume E, Cole N, Conibear T, Glasson M et al. Inflammation and infection and effects of the closed eye. In: Sweeney D, ed.Silicone Hydrogels: Continuous Wear Contact lenses, 2nded.Oxford, UK: Butterworth‐Heinemann, 2004. p.90–125.
   Google Scholar
• Leeming JP. Treatment of ocular infections with topical antibacterials. Clin Pharmacokinet 1999; 37: 351–360.
   PubMed Web of Science ®Google Scholar
• Gaynor BD, Chidambaram JD, Cevallos V, Miao Y, Miller K, Jha HC, Bhatta RC et al. Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol 2005; 89: 1097–1099.
   PubMed Web of Science ®Google Scholar
• Arantes TEF, Cavalcanti RF, De fátima alves diniz M, Severo MS, Neto JL, De castro CMMB. Conjunctival bacterial flora and antibiotic resistance pattern in patients undergoing cataract surgery. Arq Bras Oftalmol 2006; 69: 33–36.
   PubMedGoogle Scholar
• Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355–1359.
   PubMed Web of Science ®Google Scholar
• Duggirala A, Joseph J, Sharma S, Nutheti R, Garg P, Das T. Activity of newer fluoroquinolones against gram‐positive and gram‐negative bacteria isolated from ocular infections: An in vitro comparison. Indian J Ophthalmol 2007; 55: 15–19.
   PubMedGoogle Scholar